Hidden Gut Molecule Wrecks Kidneys
- A newly discovered connection between a bacterial molecule produced in the gut and kidney fibrosis offers potential new avenues for treating diabetic kidney disease, a leading cause of...
- A molecule made by bacteria in the gut can hitch a ride to the kidneys, where it sets off a chain reaction of inflammation, scarring and fibrosis --...
- Researchers identified high levels of corisin, a small peptide produced by Staphylococcus bacteria in the gut, in the blood of patients with diabetic kidney fibrosis.
“`html
Gut Bacteria Molecule Linked to Diabetic Kidney Failure: University of Illinois Research
Table of Contents
A newly discovered connection between a bacterial molecule produced in the gut and kidney fibrosis offers potential new avenues for treating diabetic kidney disease, a leading cause of kidney failure. Researchers at the University of Illinois Urbana-Champaign and Mie University in Japan detail their findings in a study published in Nature Communications.
A molecule made by bacteria in the gut can hitch a ride to the kidneys, where it sets off a chain reaction of inflammation, scarring and fibrosis — a serious complication of diabetes and a leading cause of kidney failure — according to a new study from researchers at the university of Illinois Urbana-Champaign and Mie University in Japan.
The Gut-Kidney Connection: How Corisin drives Fibrosis
Researchers identified high levels of corisin, a small peptide produced by Staphylococcus bacteria in the gut, in the blood of patients with diabetic kidney fibrosis. Thru computer simulations, tissue experiments, and mouse models, they traced the pathway of corisin from the gut to the kidneys and investigated its impact.
The study reveals that corisin triggers a cascade of inflammation, ultimately leading to scarring and fibrosis within the kidneys. This process contributes significantly to the progression of kidney damage in individuals with diabetes.
“Our earlier studies showed corisin can damage cells and worsen tissue scarring and fibrosis in other organs, so we suspected it might be a hidden driver of kidney fibrosis,” explained Isaac cann, a professor of animal sciences at the University of Illinois and co-leader of the study. “Our new findings suggest corisin is indeed a hidden culprit behind progressive kidney damage in diabetes, and that blocking it could offer a new way to protect kidney health in patients.”
Research Methodology and Key Findings
The research team, led by Professor Cann and Dr. Esteban Gabazza of Mie University,employed a multi-faceted approach:
- computer Simulations: To model the interaction of corisin with kidney cells.
- Tissue Experiments: To observe the direct effects of corisin on kidney tissue.
- Mouse Models: To study the progression of kidney fibrosis in a living organism.
These experiments demonstrated that corisin not only contributes to kidney damage but also that blocking its activity with antibody treatment showed promise in mitigating the effects of fibrosis.
Implications for diabetic Kidney Disease Treatment
Diabetic kidney fibrosis is a significant global health concern, responsible for a ample proportion of kidney failure cases. Despite its prevalence, the underlying mechanisms driving the disease have remained largely unknown, and effective treatments have been elusive.
This research identifies corisin as a potential therapeutic target. Blocking corisin’s activity could offer a novel strategy for preventing or slowing the progression of kidney damage in patients with diabetes. Further research is needed to develop and test antibody-based therapies in clinical trials.
“Diabetic kidney fibrosis is a major cause of kidney failure worldwide, yet the key drivers of it have remained a mystery, and no treatments can stop the process,” said Dr. Taro Yasuma of Mie University, a medical doctor involved in the study. “This finding opens up a new avenue for developing targeted therapies.”